Isomorphic Labs in early talks to raise funding at a valuation of at least $40 billion, Bloomberg reports
Bloomberg, citing sources, reports that Isomorphic Labs, the AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funding at a valuation of at least $40 billion, possibly as high as $50 billion. The talks are described as early-stage, and no round size, investors, or confirmed deal have been announced.
Bloomberg, citing sources, reports that Isomorphic Labs, the AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funding at a valuation of at least $40 billion, possibly as high as $50 billion. The talks are described as early-stage, and no round size, investors, or confirmed deal have been announced.
Key facts
- Bloomberg, citing sources, reports that Isomorphic Labs is in early talks to raise funding at a valuation of at least $40 billion.
- The valuation in the reported early funding talks could be as high as $50 billion, per Bloomberg.
- Isomorphic Labs is an AI drug discovery startup spun out of Google DeepMind.
- Isomorphic Labs is Demis Hassabis's AI drug-discovery spinout from Google DeepMind.
- The funding talks are described as early-stage; no round size, investors, or confirmed deal have been announced.
- The Bloomberg-reported valuation in the early funding talks could be as high as $50 billion.
- Crypto Briefing reports that Isomorphic Labs' valuation surge highlights growing investor confidence in AI-driven drug discovery despite the company lacking clinical data.
- Isomorphic Labs reportedly lacks clinical data, per Crypto Briefing.
Sources · 4 sources
- CB
Crypto BriefingArticle ·
Isomorphic Labs reportedly seeks funding at a valuation of at least $40 billion Isomorphic Labs' valuation surge highlights the growing investor confidence in AI-driven drug discovery, despite lacking clinical data. The post Isomorphic Labs reportedly seeks funding at a valuation of at least $40 billion appeared first on Crypto Briefing .
Open source - BL
Bloomberg@businessPost on X ·
Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. https://t.co/gYxA73ycfz
Open source - MT
MTS@MTSlivePost on X ·
SITUATION DETECTED: Isomorphic Labs, Demis Hassabis’s AI drug-discovery spinout from Google DeepMind, is in early talks to raise at a valuation of at least $40 billion, and possibly $50 billion, per Bloomberg.
Open source - TE
Techmeme@TechmemePost on X ·
Sources: Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B (Bloomberg) (Visit Techmeme dot com for the link and full context!)
Open source